Target intelligence / Profile preview

Dystrophin pre-mRNA (N/A)

Target
N/A
Molecular classification
RNA, Precursor mRNA
01

Overview

Dystrophin pre-mRNA is a large precursor transcript whose correct processing is critical for producing functional forms of one of muscle’s most important structural proteins. Its complexity underlies both its vulnerability in genetic disease and its value as a therapeutic target through exon-skipping technologies designed at this RNA level.

Other names
DMD pre-mRNADystrophin primary transcript
02

Mechanism of action

Exon skipping to restore open reading frame; translational read-through of premature stop codons.

03

Biological functions

Gene expressionPre-mRNA splicingRegulation of protein synthesis
04

Disease associations

Duchenne Muscular Dystrophy (DMD)Becker Muscular Dystrophy (BMD)
05

Safety considerations

Off-target effects of antisense oligonucleotidesImmune response to therapeutic oligonucleotidesVariable efficacy depending on mutation and patient characteristics
06

Interacting drugs

Antisense oligonucleotides

2 more in the full profile.

07

Biomarkers

Dystrophin mRNA levelsExon skipping efficiencyDystrophin protein expression

Beyond the preview

Go deeper on Dystrophin pre-mRNA (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophin pre-mRNA (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call